ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 9 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $577,000 | +38.7% | 395,948 | +35.2% | 0.00% | – |
| Q4 2016 | $416,000 | -17.5% | 292,781 | +1.6% | 0.00% | – |
| Q3 2016 | $504,000 | -10.8% | 288,054 | -12.7% | 0.00% | -100.0% |
| Q2 2016 | $565,000 | -6.0% | 330,092 | +8.5% | 0.00% | 0.0% |
| Q1 2016 | $601,000 | +58.6% | 304,236 | +52.3% | 0.00% | – |
| Q4 2015 | $379,000 | -18.1% | 199,801 | -17.3% | 0.00% | -100.0% |
| Q3 2015 | $463,000 | -80.7% | 241,721 | -53.2% | 0.00% | -50.0% |
| Q2 2015 | $2,398,000 | +107.3% | 516,935 | +95.1% | 0.00% | +100.0% |
| Q1 2015 | $1,157,000 | -42.3% | 264,944 | -54.1% | 0.00% | -50.0% |
| Q4 2014 | $2,004,000 | +59.3% | 577,445 | +92.3% | 0.00% | +100.0% |
| Q3 2014 | $1,258,000 | -69.6% | 300,344 | -57.5% | 0.00% | -66.7% |
| Q2 2014 | $4,144,000 | +83.9% | 707,054 | +97.6% | 0.00% | +50.0% |
| Q1 2014 | $2,254,000 | -70.1% | 357,812 | -72.3% | 0.00% | -75.0% |
| Q4 2013 | $7,545,000 | +36.5% | 1,289,873 | +22.9% | 0.01% | +60.0% |
| Q3 2013 | $5,528,000 | -48.9% | 1,049,108 | -25.4% | 0.01% | -54.5% |
| Q2 2013 | $10,823,000 | -14.7% | 1,405,587 | -9.1% | 0.01% | -15.4% |
| Q1 2013 | $12,689,000 | – | 1,545,511 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |